- Home
- J vs PEN Comparison
J vs PEN Comparison
Compare J & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | J | PEN |
|---|---|---|
| Founded | 1947 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.7B | 12.6B |
| IPO Year | 1994 | 2015 |
Fundamental Metrics
Financial Performance| Metric | J | PEN |
|---|---|---|
| Price | $143.47 | $324.58 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 16 |
| Target Price | $154.60 | ★ $360.14 |
| AVG Volume (30 Days) | ★ 837.8K | 370.3K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.15% | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | ★ 1.94 | 1.70 |
| Revenue | ★ $14,984,646,000.00 | $1,403,665,000.00 |
| Revenue This Year | $12.96 | $14.34 |
| Revenue Next Year | N/A | $13.71 |
| P/E Ratio | ★ $74.57 | $190.12 |
| Revenue Growth | ★ 49.51 | 17.50 |
| 52 Week Low | $105.68 | $221.26 |
| 52 Week High | $168.44 | $362.41 |
Technical Indicators
Market Signals| Indicator | J | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 68.07 | 66.72 |
| Support Level | $125.33 | $315.31 |
| Resistance Level | $155.04 | $329.67 |
| Average True Range (ATR) | 3.91 | 2.08 |
| MACD | 0.94 | 0.72 |
| Stochastic Oscillator | 66.76 | 95.91 |
Price Performance
Historical ComparisonAbout J Jacobs Solutions Inc.
Jacobs Solutions is a global provider of engineering, design, procurement, construction, and maintenance services as well as cyber engineering and security solutions. The firm serves industrial, commercial, and government clients in a wide variety of sectors, including water, transportation, healthcare, technology, and chemicals. Jacobs Solutions employs approximately 60,000 workers. The company generated $12 billion in revenue in fiscal 2025.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.